BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 21707225)

  • 41. Relationship between insulin resistance and erythropoietin responsiveness in hemodialysis patients.
    Abe M; Okada K; Soma M; Matsumoto K
    Clin Nephrol; 2011 Jan; 75(1):49-58. PubMed ID: 21176750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epoetin alfa increases hemoglobin levels and improves quality of life in anemic geriatric cancer patients receiving chemotherapy.
    Aapro MS; Dale DC; Blasi M; Sarokhan B; Ahmed F; Woodman RC
    Support Care Cancer; 2006 Dec; 14(12):1184-94. PubMed ID: 16758175
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee.
    Quirt I; Micucci S; Moran LA; Pater J; Browman G
    Cancer Prev Control; 1997 Aug; 1(3):241-8. PubMed ID: 9765749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules.
    Chaidos A; Makis A; Hatzimichael E; Tsiara S; Gouva M; Tzouvara E; Bourantas KL
    Acta Haematol; 2004; 111(4):189-95. PubMed ID: 15153710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia.
    Vaupel P; Dunst J; Engert A; Fandrey J; Feyer P; Freund M; Jelkmann W
    Onkologie; 2005 Apr; 28(4):216-21. PubMed ID: 15840971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
    Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
    J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and efficacy of erythropoietin in children with chronic renal failure.
    Brandt JR; Avner ED; Hickman RO; Watkins SL
    Pediatr Nephrol; 1999 Feb; 13(2):143-7. PubMed ID: 10229004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey.
    Del Prete S; Cinieri S; Lorusso V; Maiorino L; Pizza C; Pisano A; Montesarchio V; Leo L; Savastano C; Pistolese G; Bianco M; Mabilia R; Tonachella R; Febbraro A; Manzione L; Palazzo S; Filippelli G; Vincenzi B; Barbato E; Cennamo G; Riccardi F; Misso G; Caraglia M; Addeo R
    Future Oncol; 2014 Jan; 10(1):69-78. PubMed ID: 24328410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence.
    Crawford J
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):41-53. PubMed ID: 12380954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices.
    Trkulja V
    Med Hypotheses; 2012 Jan; 78(1):157-61. PubMed ID: 22078846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recombinant human erythropoietin for the treatment of anaemia in patients with chronic idiopathic myelofibrosis.
    Tsiara SN; Chaidos A; Bourantas LK; Kapsali HD; Bourantas KL
    Acta Haematol; 2007; 117(3):156-61. PubMed ID: 17159338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM.
    Kelaidi C; Beyne-Rauzy O; Braun T; Sapena R; Cougoul P; Adès L; Pillard F; Lamberto C; Charniot JC; Guerci A; Choufi B; Stamatoullas A; Slama B; De Renzis B; Ame S; Damaj G; Boyer F; Chaury MP; Legros L; Cheze S; Testu A; Gyan E; Béné MC; Rose C; Dreyfus F; Fenaux P
    Ann Hematol; 2013 May; 92(5):621-31. PubMed ID: 23358617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Administration of the same dose of epoetin-beta intravenously and subcutaneously to patients with renal anaemia.
    Steffensen GK; Stergaard O
    Scand J Urol Nephrol; 2011 Dec; 45(6):461-9. PubMed ID: 21736448
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of erythropoietin on dialysis in patients with beta thalassemia minor.
    Di Iorio B; De Nicola L; Bellizzi V; Minutolo R; Zamboli P; Rubino R; Fuiano G; Conte G
    Blood Purif; 2004; 22(5):453-60. PubMed ID: 15359104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer.
    Smith RE; Jaiyesimi IA; Meza LA; Tchekmedyian NS; Chan D; Griffith H; Brosman S; Bukowski R; Murdoch M; Rarick M; Saven A; Colowick AB; Fleishman A; Gayko U; Glaspy J
    Br J Cancer; 2001 Apr; 84 Suppl 1(Suppl 1):24-30. PubMed ID: 11308271
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recombinant human erythropoietin treatment for chemotherapy-related anemia in children.
    Varan A; Büyükpamukçu M; Kutluk T; Akyüz C
    Pediatrics; 1999 Feb; 103(2):E16. PubMed ID: 9925862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
    Ludwig H; Sundal E; Pecherstorfer M; Leitgeb C; Bauernhofer T; Beinhauer A; Samonigg H; Kappeler AW; Fritz E
    Cancer; 1995 Dec; 76(11):2319-29. PubMed ID: 8635038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia.
    Mittelman M; Zeidman A; Fradin Z; Magazanik A; Lewinski UH; Cohen A
    Acta Haematol; 1997; 98(4):204-10. PubMed ID: 9401498
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mortality risk in hemodialysis patients according to anemia control and erythropoietin dosing.
    Santos PR; Melo AD; Lima MM; Negreiros IM; Miranda JS; Pontes LS; Rabelo GM; Viana AC; Alexandrino MT; Barros FA; Neto BR; Brito AA; Da Silva Costa A
    Hemodial Int; 2011 Oct; 15(4):493-500. PubMed ID: 22111817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer.
    Glimelius B; Linné T; Hoffman K; Larsson L; Svensson JH; Näsman P; Svensson B; Helmers C
    J Clin Oncol; 1998 Feb; 16(2):434-40. PubMed ID: 9469326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.